Research output per year
Research output per year
Personal profile
Research Biography
I am a clinical epidemiologist, biostatistician, and pharmacist with a primary research interest in the use of biological, chemical, and clinical markers to guide decisions regarding the most appropriate use of medicines (precision medicine). My current research primarily focuses on evaluation and evidence development with respect to precision medicine approaches informing the use of cancer medicines. This includes analysis of pooled clinical trial data, and evaluation of patient data from routine clinical care. Additionally, I research novel biomarkers of drug exposure to better inform drug dosing.
Research Interests
- Precision/personalised medicine
- Prediction modelling of outcomes of cancer medicines in advanced cancer
- Novel methods for precision dosing of medicines
- Evidence-based medicine, clinical epidemiology, decision analysis, pharmacoeconomics and meta-analysis
Fingerprint
Dive into the research topics where Michael Sorich is active. These topic labels come from the works of this person. Together they form a unique fingerprint.
- 1 Similar Profiles
Collaborations and top research areas from the last five years
Recent external collaboration on country/territory level. Dive into details by clicking on the dots or
-
Aberrant protein expression of Appl1, Sortilin and Syndecan-1 during the biological progression of prostate cancer
Martini, C., Logan, J. M., Sorvina, A., Gordon, C., Beck, A. R., S-Y. Ung, B., Caruso, M. C., Moore, C., Hocking, A., Johnson, I. R. D., Li, K. L., Karageorgos, L., Hopkins, A. M., Esterman, A. J., Huzzell, C., Brooks, R. D., Lazniewska, J., Hickey, S. M., Bader, C., Parkinson-Lawrence, E., & 30 others, Feb 2023, In: Pathology. 55, 1, p. 40-51 12 p.Research output: Contribution to journal › Article › peer-review
Open AccessFile1 Citation (Scopus)21 Downloads (Pure) -
Analysis of Extracellular Vesicle and Contaminant Markers in Blood Derivatives Using Multiple Reaction Monitoring
Newman, L. A., Useckaite, Z., Wu, T., Sorich, M. J. & Rowland, A., 12 Feb 2023, Serum/Plasma Proteomics: Methods in Molecular Biology. Greening, D. W. & Richard J., R. J. (eds.). New York: Springer Nature, p. 301-320 20 p. (Methods in molecular biology (Clifton, N.J.); vol. 2628).Research output: Chapter in Book/Report/Conference proceeding › Chapter › peer-review
-
Artificial intelligence chatbots will revolutionize how cancer patients access information: ChatGPT represents a paradigm-shift
Hopkins, A. M., Logan, J. M., Kichenadasse, G. & Sorich, M. J., Apr 2023, In: JNCI Cancer Spectrum. 7, 2, 3 p., pkad010.Research output: Contribution to journal › Review article › peer-review
Open AccessFile3 Citations (Scopus)4 Downloads (Pure) -
Association between patient-reported outcomes and therapeutic outcomes in patients with breast cancer: A pooled individual-participant data analysis
Modi, N., Abuhelwa, A. Y., Rowland, A., Menz, B. D., McKinnon, R. A., Sorich, M. J. & Hopkins, A. M., 1 Jun 2023, In: Journal of Clinical Oncology. 41, 16_suppl, p. 530 1 p.Research output: Contribution to journal › Meeting Abstract › peer-review
-
Female reproductive status and exogenous sex hormone use in rheumatoid arthritis patients treated with tocilizumab and csDMARDs
Daraghmeh, D. N., Hopkins, A. M., King, C., Abuhelwa, A. Y., Wechalekar, M. D., Proudman, S. M., Sorich, M. J. & Wiese, M. D., Feb 2023, In: Rheumatology (Oxford, England). 62, 2, p. 583-595 13 p.Research output: Contribution to journal › Article › peer-review
Open AccessFile6 Downloads (Pure)
Activities
- 1 Other
-
Pharmacogenomics, Australian Pharmaceutical Formulary
C. A. Haddy (Participant), Ross McKinnon (Participant), Michael Sorich (Participant) & M Ward (Participant)
2006 → …Activity: Other activity types › Other